Prostate cancer
Results
Phase 3
This trial looked at a new drug called tasquinimod for men whose prostate cancer had spread to another part of the body (metastatic or secondary cancer).
Recruitment start: 28 September 2011
Recruitment end: 31 October 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Huddart
Active Biotech AB
Last reviewed: 05 Oct 2016
CRUK internal database number: 9338
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
